Medplus Health Services Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹1,679Cr
- +6.5% YoY
- +8.8% QoQ
- Net profit
- ₹56Cr
- +43.6% YoY
- +33.3% QoQ
- Margin
- 9%
- +1 pp YoY
- +1 pp QoQ
The short version
MedPlus expects gradual growth in same-store sales growth (SSSG), targeting high-single digit growth (9-10%) within the next 2 years. MedPlus expects same-store sales growth (SSSG) to gradually improve to high-single digits (9%-10%) within the next 2 years.
From Medplus Health Services Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- MedPlus expects gradual growth in same-store sales growth (SSSG), targeting high-single digit growth (9-10%) within the next 2 years.
- The company aims to continue adding 600 to 1,000 stores annually, including a mix of owned and franchisee stores.
- Private label non-pharma category is growing steadily due to improved store layouts and increased impulsive buying.
- Revenue growth is supported by deepening presence in southern and eastern India, with initial expansion into states like Chhattisgarh and Madhya Pradesh.
- Diagnostics segment is currently a small part (<2%) and will expand only after crossing subscription thresholds.
2 more points from Medplus Health Services Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Diagnostics segment: No immediate expansion planned until subscription numbers cross 250,000.
- Current diagnostic capex: INR 120+ crores spent to set up 12 diagnostic centers, including 4 large centers.
- Future diagnostics expansion: On hold until better subscription numbers are achieved.
- Store network expansion: Planning to add 600 to 1,000 stores annually (including franchisees).
- Franchisee model: Still in pilot phase; future growth dependent on franchisee adoption.
- Supply chain: New warehouses added and functional to improve fill rates.
2 more points from Medplus Health Services Ltd's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Medplus Health Services Ltd said on order book & pipeline — free account, 30 seconds.
Medplus Health Services Ltd — Quarterly revenue & net profit
Medplus Health Services Ltd Q2 FY26 results — key figures
| ₹ Cr | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,679 | 1,576 | +6.5% | 1,543 | +8.8% |
| Operating profit (EBITDA) | 149 | 124 | +20.2% | 131 | +13.7% |
| Operating margin | 9% | 8% | +1 pp | 8% | +1 pp |
| Profit before tax | 69 | 48 | +43.8% | 53 | +30.2% |
| Net profit (PAT) | 56 | 39 | +43.6% | 42 | +33.3% |
| EPS (₹) | 4.63 | 3.24 | +42.9% | 3.54 | +30.8% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.0K Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Medplus Health's management said in earlier quarters
Others in Retailing this season
- Entero Healthcar (Q2 FY26)
Growth driven by three factors: organic growth (13.4% in Q2), full-year impact of past acquisitions, and new acquisitions closing primarily in H2. Key concall…
- Matrimony.com (Q2 FY26)
The company is investing a few crores each quarter experimenting with new initiatives, including AI-based astrology services and adjacent businesses like…
- Intrasoft Technologies (Q2 FY26)
Revenue from Operations for the quarter ended September 25, 2025: ₹13,251.45 lakhs . Key investor presentation takeaways from Intrasoft Technologies's Q2 FY26 i
- RattanIndia Ent (Q2 FY26)
2,072 crore, up 18% from Rs. Key investor presentation takeaways from RattanIndia Enterprises Ltd's Q2 FY26 investor presentation — and how it ranks against sec
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Medplus Health Services Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Medplus Health Services Ltd Q2 FY26 results?
MedPlus expects gradual growth in same-store sales growth (SSSG), targeting high-single digit growth (9-10%) within the next 2 years. MedPlus expects same-store sales growth (SSSG) to gradually improve to high-single digits (9%-10%) within the next 2 years.
What is Medplus Health Services Ltd share price analysis?
Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 39.4 with a market cap of ₹8,293 Cr. Investors should review the full earnings analysis for detailed insights.
Is Medplus Health Services Ltd planning capital expenditure?
Diagnostics segment: No immediate expansion planned until subscription numbers cross 250,000.
Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
